Financials data is unavailable for this security.
View more
Year on year EnBio Holdings Inc 's net income fell -12.72% from 812.06m to 708.77m despite revenues that grew 17.92% from 8.12bn to 9.58bn. An increase in the cost of goods sold as a percentage of sales from 65.96% to 74.06% was a component in the falling net income despite rising revenues.
| Gross margin | 29.16% |
|---|---|
| Net profit margin | 9.72% |
| Operating margin | 10.59% |
| Return on assets | 4.77% |
|---|---|
| Return on equity | 10.61% |
| Return on investment | 6.02% |
More ▼
Cash flow in JPYView more
In 2024, EnBio Holdings Inc increased its cash reserves by 27.71%, or 775.43m. The company earned 1.71bn from its operations for a Cash Flow Margin of 17.88%. In addition the company generated 638.92m cash from financing while 1.58bn was spent on investing.
| Cash flow per share | 164.62 |
|---|---|
| Price/Cash flow per share | 3.69 |
| Book value per share | 1,092.22 |
|---|---|
| Tangible book value per share | 1,034.76 |
More ▼
Balance sheet in JPYView more
| Current ratio | 1.79 |
|---|---|
| Quick ratio | 1.13 |
| Total debt/total equity | 1.04 |
|---|---|
| Total debt/total capital | 0.5064 |
More ▼
Growth rates in JPY
Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items fell by -27.34%.
| Div yield(5 year avg) | 0.67% |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | 7.32% |
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 50.36 |
More ▼
